Fukuda Denshi Co., Ltd.

Equities

6960

JP3806000000

Advanced Medical Equipment & Technology

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-24 am EDT			5-day change	1st Jan Change
6,330 ^JPY	-0.47%		-3.21%	-14.11%

May. 15	Fukuda Denshi Co., Ltd Announces Notice on Shareholder Proposal	CI
Feb. 21	Fukuda Denshi Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024	CI

Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023

August 16, 2022 at 09:00 pm EDT

Fukuda Denshi Co., Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2023. For the year, the company expects to report net sales of JPY 120,000 million, operating profit of JPY 16,000 million and profit attributable to owners of parent of JPY 11,000 million or JPY 727.34 per share.

Latest news about Fukuda Denshi Co., Ltd.

Fukuda Denshi Co., Ltd Announces Notice on Shareholder Proposal	May. 15	CI
Fukuda Denshi Co., Ltd. Revises Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 20	CI
Fukuda Denshi Co., Ltd. Provides Special Dividend Guidance for the Year Ending March 31, 2024	Feb. 20	CI
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	Feb. 20	CI
Fukuda Denshi Co., Ltd. Revises Dividend Guidance for the Fiscal Year Ending March 31, 2024	Feb. 20	CI
Senzime Licensee Fukuda Denshi Launches Integrated Tetragraph Module in Japanese Market	Feb. 07	CI
Tranche Update on Fukuda Denshi Co., Ltd.'s Equity Buyback Plan announced on January 31, 2024.	Jan. 31	CI
Fukuda Denshi Co., Ltd.'s Equity Buyback announced on January 31, 2024, has closed with 1,428,700 shares, representing 4.72% for ¥11,258.16 million.	Jan. 31	CI
Fukuda Denshi Co., Ltd. announces an Equity Buyback for 2,000,000 shares, representing 6.61% for ¥15,760 million.	Jan. 31	CI
Fukuda Denshi Co., Ltd. authorizes a Buyback Plan.	Jan. 30	CI
Fukuda Denshi’s Attributable Profit up 20.8% in Fiscal H1	Nov. 20	MT
Fukuda Denshi Co., Ltd. Provides Ordinary Dividend Guidance for the Ending March 31, 2024	Nov. 19	CI
Fukuda Denshi Co., Ltd. Announces Extra Dividend for the Second Quarter Ended September 30, 2023, Scheduled Date for Commencement of Dividend Payment of December 4, 2023 and Provides Dividend Guidance for the Ending March 31, 2024	Nov. 19	CI
Fukuda Denshi Co., Ltd. Announces Ordinary Dividend for the Second Quarter Ended September 30, 2023, Scheduled Date for Commencement of Dividend Payment of December 4, 2023	Nov. 19	CI
Fukuda Denshi Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	23-10-25	CI
Cross SYNC. Inc. announced that it has received ¥510 million in funding from a group of investors	23-08-29	CI
Fukuda Denshi Co., Ltd. Provides Extra Dividend Guidance for the Second Quarter-End and Year-End for the Year Ending March 31, 2024	23-07-30	CI
Fukuda Denshi Co., Ltd. Provides Ordinary Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	23-07-30	CI
Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	23-07-30	CI
Fukuda Denshi Announces Voting Results	23-07-03	CI
Fukuda Denshi Co., Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2024	23-05-22	CI
Fukuda Denshi Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-15	CI
Fukuda Denshi Announces Notice on Shareholder Proposal	23-05-15	CI
AI Silk Corporation announced that it has received ¥320 million in funding from Global Brain Co., Ltd., EPSON X Investment Corporation, Fukuda Denshi Co., Ltd., Mizuho Capital Co., Ltd., Tohoku University Venture Partners Co.,Ltd.	23-05-14	CI
Cross SYNC. Inc. announced that it expects to receive ¥280 million in funding from a group of investors	23-04-06	CI

Chart Fukuda Denshi Co., Ltd.

Duration

Period

More charts

Company Profile

FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-30 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
FUKUDA DENSHI CO., LTD.	-14.11%	1.17B
THERMO FISHER SCIENTIFIC	+10.03%	223B
DANAHER CORPORATION	+13.59%	194B
INTUITIVE SURGICAL, INC.	+20.01%	141B
BOSTON SCIENTIFIC CORPORATION	+30.83%	109B
SIEMENS HEALTHINEERS AG	+2.05%	64.85B
EDWARDS LIFESCIENCES CORPORATION	+15.38%	52.7B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	51.77B
AGILENT TECHNOLOGIES, INC.	+8.37%	44.12B
GE HEALTHCARE TECHNOLOGIES INC.	+3.27%	36.21B

Other Advanced Medical Equipment & Technology